Series D Financing – UF Innovate https://innovate.research.ufl.edu Building business on innovation Fri, 12 Sep 2025 15:11:58 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png Series D Financing – UF Innovate https://innovate.research.ufl.edu 32 32 Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need (Bio Space) https://innovate.research.ufl.edu/kriya-announces-320-million-series-d-financing/ Thu, 11 Sep 2025 14:40:50 +0000 https://innovate.research.ufl.edu/?p=19883 UF startup Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, announced the closing of a $320 million Series D financing. The round was co-led by Patient Square Capital and Premji Invest, with participation from other leading life sciences and technology-focused investors including Peter Thiel, Narya Capital, The T1D Fund: A Breakthrough T1D Venture, LLC and other long-term investors. The round was oversubscribed and completed at a significant step up to the previous round of financing. Akshay Rai from Premji Invest has joined Kriya’s Board of Directors in conjunction with this financing.

 

Read more about Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need.

]]>